Kamada (KMDA) Total Liabilities (2012 - 2026)
Kamada's (KMDA) quarterly Total Liabilities came in at $383.0 million in Q1 2026, up 2.11% YoY from $375.1 million in Q1 2025, and up 1.14% on a QoQ basis from $378.7 million in Q4 2025.
Kamada (KMDA) Total Liabilities (2012 - 2026) Analysis & Trends
Kamada (KMDA) has 13 years of Total Liabilities data on file, last reported at $383.0 million in Q1 2026.
- Quarterly Total Liabilities rose 2.11% year-over-year to $383.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $383.0 million (up 2.11% YoY) and the FY2025 annual result came in at $378.7 million, up 1.73% from the prior year.
- Total Liabilities climbed to $383.0 million in Q1 2026, from $378.7 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $343.2 billion in Q1 2024 to a low of $303.1 million in Q1 2022.
- A 5-year average of $77.7 billion and a median of $372.3 million in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities surged 133182183.33% — and 2024, when it plunged 99.9%.
- Tracing KMDA's Total Liabilities over 5 years: stood at $322.4 million in 2022, then rose by 10.09% to $354.9 million in 2023, then increased by 4.89% to $372.3 million in 2024, then increased by 1.73% to $378.7 million in 2025, then increased by 1.14% to $383.0 million in 2026.
- The last three Total Liabilities figures came in at $383.0 million (Q1 2026), $378.7 million (Q4 2025), and $377.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 2.12 Bn |
| 10 | Kamada | 465.78 Mn | 436.31 Mn | 22.47 Mn | 383.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 383.16 Mn |
| Mar 31, 2026 | 383.02 Mn |
| Dec 31, 2025 | 378.71 Mn |
| Sep 30, 2025 | 377.21 Mn |
| Jun 30, 2025 | 368.17 Mn |
| Mar 31, 2025 | 375.11 Mn |
| Dec 31, 2024 | 372.26 Mn |
| Sep 30, 2024 | 351.21 Mn |
| Jun 30, 2024 | 351.04 Mn |
| Mar 31, 2024 | 343.17 Bn |
| Dec 31, 2023 | 354.91 Mn |
| Sep 30, 2023 | 337.06 Bn |
| Jun 30, 2023 | 314.39 Mn |
| Mar 31, 2023 | 316.80 Bn |
| Dec 31, 2022 | 322.38 Mn |
| Sep 30, 2022 | 319.64 Bn |
| Jun 30, 2022 | 304.14 Mn |
| Mar 31, 2022 | 303.10 Mn |
| Dec 31, 2021 | 318.67 Mn |
| Sep 30, 2021 | -240,000.00 |